Ocular Therapeutix (OCUL) Debt to Equity (2016 - 2025)
Historic Debt to Equity for Ocular Therapeutix (OCUL) over the last 13 years, with Q4 2025 value amounting to $0.11.
- Ocular Therapeutix's Debt to Equity fell 4981.34% to $0.11 in Q4 2025 from the same period last year, while for Dec 2025 it was $0.11, marking a year-over-year decrease of 4981.34%. This contributed to the annual value of $0.11 for FY2025, which is 4981.34% down from last year.
- Ocular Therapeutix's Debt to Equity amounted to $0.11 in Q4 2025, which was down 4981.34% from $0.27 recorded in Q3 2025.
- Ocular Therapeutix's Debt to Equity's 5-year high stood at $8.29 during Q3 2023, with a 5-year trough of $0.11 in Q4 2025.
- Over the past 5 years, Ocular Therapeutix's median Debt to Equity value was $0.28 (recorded in 2021), while the average stood at $1.19.
- Its Debt to Equity has fluctuated over the past 5 years, first soared by 187680.11% in 2023, then crashed by 9767.7% in 2024.
- Ocular Therapeutix's Debt to Equity (Quarter) stood at $0.28 in 2021, then soared by 151.29% to $0.71 in 2022, then rose by 1.12% to $0.72 in 2023, then tumbled by 69.91% to $0.22 in 2024, then tumbled by 49.81% to $0.11 in 2025.
- Its last three reported values are $0.11 in Q4 2025, $0.27 for Q3 2025, and $0.23 during Q2 2025.